Navigation Links
One third of stunting and a quarter of deaths among under 3s in poor countries could be prevented
Date:1/16/2008

If existing maternal and child nutrition interventions were implemented in poor countries, cases of stunting among under 3s could be reduced by a third, and deaths by up to a quarter, according to new research being published today.

Professor Simon Cousens, of the London School of Hygiene & Tropical Medicine, is one of the authors of a paper which appears as part of the Lancet Maternal and Child Undernutrition Series, which is being launched this week. Professor Cousens, along with four other series authors, is presenting his findings at a press event at the Science Media Centre.

178 million children under five are stunted, and most of these live in Sub-Saharan Africa and south-central Asia. 160 million stunted children (90%) live in just 36 countries, and make up 46% of the 348 million children in those countries. In addition, 19 million children are affected by severe acute malnutrition.

Historical evidence of improvements in nutrition in developed countries has shown that stature, living standards, reduced disease exposure and education are linked, and that almost all stunting is avoidable. Stunting is difficult to reverse after the age of three, so it is important to focus on interventions in pregnancy and in young children, especially those aged under two. In the past most nutrition programme reports and assessments have focused on weight gain rather than linear growth, and linear-growth retardation has been viewed as difficult to change. However, in the short term, about one third of stunting could be averted with existing interventions, say the authors. These include strategies to promote improved complementary feeding, micronutrient interventions, and interventions aimed at reducing the burden of disease.

In addition to reducing stunting, nutrition interventions, including breastfeeding promotion, could prevent about one quarter of child deaths in the 36 countries in which 90% of the worlds stunted children live, whil
'/>"/>

Contact: Gemma Howe
gemma.howe@lshtm.ac.uk
020-792-72802
London School of Hygiene & Tropical Medicine
Source:Eurekalert

Page: 1 2

Related medicine news :

1. STERIS Corporation Announces Date of Fiscal 2008 Third Quarter Earnings Release and Conference Call
2. American Life League Announces Third Training and Activism Weekend
3. ForSight Labs, LLC Announces Formation of Its Third Company, ForSight VISION3, Inc. and Closing of $6 Million in Series A Funding
4. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Third Quarter Earnings
5. The Ensign Group, Inc. Reports Third Quarter 2007 Earnings
6. Par Pharmaceutical Reports Third-Quarter 2007 Results
7. AHIP Releases Individual Market Guarantee Access Proposal, Announces Support for Third Party Review of Rescission Decisions
8. China Sky One Medical Completes Previously Announced Amendments to Form 10QSB for the Second and Third Quarters of 2006
9. AIRLIFE Denver Spreads its Wings with Third Helicopter
10. Surgical Care Affiliates Announces Investor Conference Call to Discuss Third Quarter 2007 Results
11. The Ensign Group, Inc. to Announce Third Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)... , , SATURDAY, Dec. 5 (HealthDay News) -- ...d asthma can have bad reactions to certain holiday...ent sneezing and wheezing, according to the Americ...I). , Those who are allergic to live evergreens ma...oth live and artificial trees can trigger symptoms...
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd (NYSE: AWH ) today announced that Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive Vice,Pres
(Date:12/4/2009)ANAHEIM, Calif., Dec. 4 Pamela Bowen, Chief Information Officer at Crescent Healthcare, was selected as a finalist for the "Chief Innovation Officer" Appy Award for transforming Crescent,s business w
(Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel
Breaking Medicine News(10 mins):Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3
... its ReNu with MoistureLoc contact lens solution b...e associated with it. Now in a new study from Uni... show that these infections were fueled and made r...call this conglomeration of cells biofilms. , On...
...monitoring of biomarkers used by, physicians to he...ses and conditions, ...nnounced today the availability of the Biophysical... usually missed in,standard annual physicals. Thro...
...p Kids Receive Care, CHICAGO, Jan. 28 In honor o...ruary, the Wm. Wrigley Jr. Company,(NYSE: WWY ) i...oss sales in,the U.S. (up to another $100,000) of ... health education,screening and treatment services...
...mical Society (ACS) News Service Weekly PressPac w...emical & Engineering News.,Please credit the indiv...the source for this information. , ALL CONTENT IS...telepathy? A bizarre new property of DNA, Journal...
...ay led to spikes in blood sugar levels , ,...suggests the caffeine in those daily cups of java ...n a small group of 10 diabetics, glucose levels ro...e consumption -- and coffee is the most common sou...
...lletin,Board: NTRZ), a world leader in stabilized ... today provided an update on its domestic,operatio...ty located in Dillon,Montana has been running at f...is fully committed to run at full capacity,through...
Other Medicine News:Health News:New study finds resistant organisms at core of soft contact lens corneal infections 2Health News:Biophysical Unveils BiophysicalCheck Health Assessment Program to Aid in Pre-Symptomatic Detection of Disease 2Health News:Biophysical Unveils BiophysicalCheck Health Assessment Program to Aid in Pre-Symptomatic Detection of Disease 3Health News:Wrigley Keeps Kids Smiling Through Donation to American Dental Association Program 2Health News:Wrigley Keeps Kids Smiling Through Donation to American Dental Association Program 3Health News:Wrigley Keeps Kids Smiling Through Donation to American Dental Association Program 4Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 2Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 3Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 4Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 5Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 6Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 7Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 8Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 9Health News:American Chemical Society's weekly PressPac -- Jan. 23, 2008 10Health News:Caffeine Could Spell Trouble for Diabetics 2Health News:NutraCea Provides Update on Domestic Operations 2Health News:NutraCea Provides Update on Domestic Operations 3
(Date:12/3/2009)SAN DIEGO, Dec. 3 BioMed Realty Trust, Inc. (NYSE: BMR ) announced today that it has entered into a new lease with Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) for approximately 131,000 square
(Date:12/3/2009)WILMINGTON, Del., Dec. 3 ParagonRx, a Delaware-based company specializing in pharmaceutical risk management and optimal medication use, will host a free webinar on Wednesday, Dec. 9, on the FDA,s dra
(Date:12/3/2009)FORT WORTH, Texas, Dec. 3 Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM), a rapidly growing provider of specialty medical products, announced today an agreement with the Health In
Breaking Medicine Technology:BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 3Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 2Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 3Centrix Pharmaceutical Announces Clofera 28TM 29 a Unique Antitussive and Nasal Decongestant for the Temporary Relief of Cough and Nasal Congestion 54520 1Centrix Pharmaceutical Announces Clofera 28TM 29 a Unique Antitussive and Nasal Decongestant for the Temporary Relief of Cough and Nasal Congestion 54520 2CordLife Makes Headway into China 54519 1CordLife Makes Headway into China 54519 2CordLife Makes Headway into China 54519 3CordLife Makes Headway into China 54519 4CordLife Makes Headway into China 54519 5Oxygen Biotherapeutics Inc to Begin Oxycyte 28R 29 Phase II Clinical Trials in Switzerland 54517 1Oxygen Biotherapeutics Inc to Begin Oxycyte 28R 29 Phase II Clinical Trials in Switzerland 54517 2Oxygen Biotherapeutics Inc to Begin Oxycyte 28R 29 Phase II Clinical Trials in Switzerland 54517 3
...ration Oxazolidinone Enrolls in Four Months , , ... announced the completion of enrollment in its ran...ng the oral dosage form of torezolid (also known a...in structure infections (cSSSI). The trial, which...States, examined the efficacy and safety of three ...
.... 23 Today the FDA announced,approval for the fir...Cells,but Adult Stem Cell scientist Christian Drap...story; Adult Stem Cells have greater potential wit...xciting step forward toward freeing science,from t...t commentary we,re,seeing surrounding the FDA,s ac...
Other Medicine Technology:Trius Completes Enrollment in Phase 2 Clinical Trial Evaluating Torezolid (TR-701) in Patients With Complicated Skin and Skin Structure Infections 2FDA Stem Cell Approval Breakthrough Laudable 2
...e HF-compatible V series from Pentax, the standard...ed., ,The HF-compatible series of fibre bronchosc...d FB-15V models along with the very slim FB-10V an...lity thanks mainly to the higher resolution and wi...
BRO-YP2 Pediatric Bronchoscope
OES BF-40 Bronchoscope
...ofiberscopes with electrosurgical capability, has ...nd for expanded bronchoscopic diagnostic and treat...l section and ergonomic design to facilitate incre...eld of view, a smaller insertion tube and distal e...
Medicine Products: